About
Antibody Therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyBoston & New England
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
275
By Phase
PHASE1: 2
By Status
RECRUITING: 1SUSPENDED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06240728Lead Sponsor
A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2
PHASE1Recruiting
144 participants
Started: Jan 22, 2024 · Completed: Aug 31, 2027
NCT05958199Lead Sponsor
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
PHASE1Suspended
131 participants
Started: Jul 21, 2023 · Completed: Sep 20, 2025
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...